Medivir AB engages in the development of pharmaceuticals products. The firm focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipelines such as remetinostat, birinapant, MV-818, MV-828, and MIV-711 projects, and partnership pipeline which covers xerclear and MIV-802 project. The company was founded in 1988 and is headquartered in Huddinge, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10
Frequently Asked Questions
What is Market Cap of Medivir AB?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medivir AB market cap is $45.79M.
What is the 52-week high for Medivir AB?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medivir AB 52 week high is $0.90 as of September 06, 2025.
What is the 52-week low for Medivir AB?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medivir AB 52 week low is $0.68 as of September 06, 2025.
What is Medivir AB stock price today?
Medivir AB stock price today is $0.82.
What was Medivir AB stock price yesterday?
Medivir AB stock price yesterday was $0.74.
What is the PE ratio of Medivir AB?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medivir AB’s P/E ratio is -6.31.
What is the Price-to-Book ratio of Medivir AB?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medivir AB P/B ratio is 2.7252.
What is the 50-day moving average of Medivir AB?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medivir AB 50-day moving average is $0.82.
